Australia markets closed

    -0.90 (-0.01%)

    -0.0023 (-0.31%)
  • ASX 200

    +1.70 (+0.03%)
  • OIL

    -0.16 (-0.36%)
  • GOLD

    +5.30 (+0.29%)

    -297.79 (-1.15%)
  • CMC Crypto 200

    -8.48 (-2.23%)

Global Benzocaine Market to Surpass US$ 155.3 Million by 2027, Says Coherent Market Insights (CMI)

·4-min read

According to Coherent Market Insights, the global benzocaine market is estimated to be valued at US$ 128.9 million in 2020 and is expected to exhibit a CAGR of 2.70 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Benzocaine Market:

Increasing prevalence of hemorrhoids in adults globally is a major factor that is expected to drive growth of the benzocaine market over the forecast period. According to US National Library of Medicine report published in 2019, approximately 4 to 8% of individuals are suffering from hemorrhoids and only one third percent of individuals undergo treatment in the U.S. Moreover, according to the same source, approximately 13-36 % of individuals in the U.K. were suffering from hemorrhoid in 2019.

Moreover, increasing prevalence of urinary tract infection in adult females globally is leading to increasing use of local anesthetics such as benzocaine for relieving vaginal irritation caused due to this infection. Such factors are driving growth of the global benzocaine market. According to US National Library of Medicine report Published in 2019, the prevalence of UTI in females over 65 years of age is approximately 20% and prevalence of UTI is approximately 50% to 60% in adult women in the US.

Among region, North America benzocaine market is expected to register higher growth rate, as key companies are focusing on benzocaine API product launches and product approvals for the treatment of sexual disorders in males. For instance, in 2019, Veru Healthcare, a biopharmaceutical company focused on urology and oncology, announced the launch of PREBOOST (topical 4% benzocaine wipes) in the U.S. PREBOOST wipes help in the prevention of premature ejaculation (PE) in males.

Request Sample Copy of this Report @

Key Market Takeaways:

The global benzocaine market is expected to exhibit a CAGR of 2.70 % over the forecast period, owing to increasing prevalence of hemorrhoids and urinary tract infections in females, and key companies focusing on benzocaine API product launches for the treatment of various diseases such as hemorrhoids and anal fissures.

Competitive Landscape:

Key players operating in the global benzocaine market include TCI Chemicals (India) Pvt. Ltd, Merck KGaA, ACETO Corporation, Alfa Aesar, Penta International Corporation, abcr GmbH, Indofine Chemical Co Inc, Jinzhou Jiutai Pharmaceutical Co., Ltd, Changzhou Sunlight Pharmaceutical Raw Material Co., Ltd, Fengchen Group Co., Ltd, and Mahendra Chemicals.

Buy-Now this Research Report @

Market Segmentation:

  • Global Benzocaine Market, By Purity :

    • 95%

    • 98%

    • Others

  • Global Benzocaine Market, By Indication :

    • Skin Irritation

    • Wounds

    • Ulcers

    • Hemorrhoids

    • Others

  • Global Benzocaine Market, By Region:

    • North America

      • U.S.

      • Canada

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest of Europe

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

      • ASEAN

      • Rest of Asia Pacific

    • Middle East

      • GCC

      • Israel

      • Rest of Middle East

    • Africa

      • South Africa

      • Central Africa

      • North Africa

Related Market Intelligence Report:

Anesthesia and Respiratory Devices Market, by Product Type (Anesthesia Devices {Anesthesia Monitoring System and Basic Anesthesia Monitors), Anesthesia Machines (Portable Anesthesia Machines and Standalone Anesthesia Machines), Anesthesia Workstation, Anesthesia Ventilators, and Anesthesia Disposables and Accessories}) and (Respiratory Devices (Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Inhalers, Humidifiers, Oxygen Concentrators, Reusable Resuscitators, Respiratory Mask, Nitric Oxide Delivery Units, and Others), Monitoring Devices (Pulse Oximeters, Capnographs, and Gas Analyzers), Diagnostic Devices (Spirometer, Peak Flow Meters, Polysomnography Devices, and Others) and Consumables and Accessories (Tracheostomy Tubes, Nasal Cannulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more:

Cold, Cough, and Sore Throat Remedies Market, By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others), By Formulation (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores Supermarkets/Hypermarkets, E-Commerce/Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Read more:

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

View source version on


Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Follow Us: LinkedIn | Twitter